Humira Kickback Claims Spawn Investor Suit Against AbbVie
Just days after California regulators accused AbbVie Inc. of engaging in a massive kickback scheme that tainted $1.3 billion in insurance claims for its blockbuster immunosuppressant Humira, investors followed up with...To view the full article, register now.
Already a subscriber? Click here to view full article